The Invesco Global Focus fund has a refreshingly simple approach: understand the structural trends which are changing the world and then invest in the best companies which are benefitting from these trends. John Delano, co-manager on the fund, explains how the managers’ go about identifying these themes, the importance of scale and monetisation and gives examples in cloud computing and medical devices to illustrate his point. Current lead manager on the fund, Randall Dishman, is retiring in June 2023 and John tells listeners what they can expect when he takes over.

What’s covered in this episode: 

• How the managers identify structural themes in the world
• Understanding the monetisation of themes and how they can be scaled
• Monetising the aging population theme
• Why medical technology companies are undervalued
• The businesses that help develop the drugs as opposed to discovering the drugs
• Why industry publications add value to healthcare research
• How long the managers usually hold a stock
• Why allocation to China has increased in the short-term 
• What investors can expect when John becomes lead manager in summer 2023

More about the fund:
The Invesco Global Focus fund is a high conviction, concentrated fund of around 35 stocks, which invests in structural growth winners. The managers have a no-nonsense philosophy and investment process — buy companies which are winning and then let them compound over time. Current trends the fund considers include the rise of e-commerce, digital payments, cloud computing, network security software, life sciences tools, mobile technologies, social media and digital customer service.

Learn more on fundcalibre.com

Please remember, we’ve been discussing individual companies to bring investing to life for you. It’s not a recommendation to buy or sell. The fund may or may not still hold these companies at the time of listening. Elite Ratings are based on FundCalibre’s research methodology and are the opinion of FundCalibre’s research team only.

Learn more on fundcalibre.com

Please remember, we’ve been discussing individual companies to bring investing to life for you. It’s not a recommendation to buy or sell. The fund may or may not still hold these companies at the time of listening. Elite Ratings are based on FundCalibre’s research methodology and are the opinion of FundCalibre’s research team only.